Found: 11
Select item for more details and to access through your institution.
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
- Published in:
- Nagoya Journal of Medical Science, 2021, v. 83, n. 4, p. 683, doi. 10.18999/nagjms.83.4.683
- By:
- Publication type:
- Article
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity.
- Published in:
- Oncolytic Virotherapy, 2017, v. 6, p. 31, doi. 10.2147/OV.S127179
- By:
- Publication type:
- Article
Evaluation of antiviral activity of Oligonol, an extract of Litchi chinensis, against betanodavirus.
- Published in:
- Drug Discoveries & Therapeutics, 2013, v. 7, n. 6, p. 254, doi. 10.5582/ddt.2013.v7.6.254
- By:
- Publication type:
- Article
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 356, doi. 10.3390/cancers10100356
- By:
- Publication type:
- Article
STING activator 2′3′‐cGAMP enhanced HSV‐1‐based oncolytic viral therapy.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 5, p. 1259, doi. 10.1002/1878-0261.13603
- By:
- Publication type:
- Article
Genomic Signature of the Natural Oncolytic Herpes Simplex virus HF10 and its Therapeutic Role in Preclinical and Clinical Trials.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00149
- By:
- Publication type:
- Article
Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8<sup>+</sup>PD‐1<sup>−</sup> tumor‐infiltrating T cells in PD‐L1‐enriched tumor microenvironment.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 214, doi. 10.1002/ijc.33550
- By:
- Publication type:
- Article
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 7, p. 1718, doi. 10.1002/ijc.29163
- By:
- Publication type:
- Article
C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1502, doi. 10.3390/cells10061502
- By:
- Publication type:
- Article
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 698, p. 1, doi. 10.1126/scitranslmed.ade8732
- By:
- Publication type:
- Article